Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-23

Clinical Trial Update: Treatment of Diabetes After Gastric Bypass With Sitagliptin [NA]

View source ↗

Summary

This clinical trial update reports results of using sitagliptin to treat Type 2 diabetes after gastric bypass surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: Blandine Laferrere | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2018-02-23